Name of this trial: Majestic-7 What type of cancer is this for? Multiple Myeloma Who is this trial for? This trial is for patients with newly diagnosed multiple myeloma who are either ineligible or not intended for stem cell transplant as initial therapy. What biomarkers are involved? n/a What is the National Clinical Trial #? NCT05552222 Brief summary of
Phone: (800) 411-7999
